Barriers to Care of Chronic Hepatitis Patients in Latin America

Archives of Medical Research

Volumn 38, Issue 6, 2007, Pages 711-715

  Strauss, Edna ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Chronic hepatitis; Hepatitis B; Hepatitis C; Medical care; Surveillance; Treatment barriers

Indexed keywords

ADEFOVIR; ANTIVIRUS AGENT; ENTECAVIR; ERYTHROPOIETIN; HEPATITIS C ANTIBODY; INTERFERON; LAMIVUDINE; NUCLEOSIDE; PEGINTERFERON; RIBAVIRIN; TELBIVUDINE;

CHRONIC HEPATITIS; CHRONICITY; DIAGNOSTIC TEST; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; PATIENT CARE; PHYSICIAN; REVIEW; SOUTH AND CENTRAL AMERICA; SYMPTOM;

ANTIVIRAL AGENTS; CONTINUITY OF PATIENT CARE; DELIVERY OF HEALTH CARE; DISEASE MANAGEMENT; EARLY DIAGNOSIS; HEALTH CARE COSTS; HEALTH EDUCATION; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; LATIN AMERICA; POPULATION SURVEILLANCE; QUALITY OF HEALTH CARE;

EID: 34347220110     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2007.02.002     Document Type: Review

References (36)

1. Morales L.S., Lara M., Kington R.S., Valdez R.O., and Escarce J.J. Socioeconomic, cultural, and behavioral factors affecting Hispanic health outcomes. J Health Care Poor Underserved 13 (2002) 477-503
2. EASL International Consensus Conference on hepatitis C. Paris, 26-27 February 1999. Consensus statement. J Hepatol 31 (1999) S3-S8
3. NIH Consensus Statement on Management of Hepatitis C: 2002. NIH Consens State Sci Statements 19 (2002) 1-46
4. EASL International Consensus Conference on Hepatitis B. J Hepatol 39 (2003) S3-S25
5. Penchaszadeh V.B. Genetic services in Latin America. Community Genet 7 (2004) 65-69
6. Wallace S.P., and Gutierrez V.F. Equity of access to health care for older adults in four major Latin American cities. Rev Panam Salud Publica 17 (2005) 394-409
7. Wong T., and Lee S.S. Hepatitis C: a review for primary care physicians. CMAJ 174 (2006) 649-659
8. Shehab T.M., Sonnad S.S., and Lok A.S. Management of hepatitis C patients by primary care physicians in the USA: results of a national survey. J Viral Hepat 8 (2001) 377-383
9. Zickmund S., Hillis S.L., Barnett M.J., Ippolito L., and LaBrecque D.R. Hepatitis C virus-infected patients report communication problems with physicians. Hepatology 39 (2004) 999-1007
10. Shehab T.M., Orrego M., Chunduri R., and Lok A.S. Identification and management of hepatitis C patients in primary care clinics. Am J Gastroenterol 98 (2003) 639-644
11. Echevarria J.M., and Avellon A. Hepatitis B virus genetic diversity. J Med Virol 78 (2006) S36-S42
12. Sanchez-Quijano A., and Lissen E. Treatment of viral hepatitis. I. Treatment of chronic hepatitis B. Enferm Infecc Microbiol Clin 24 (2006) 453-461
13. Pol S., and Mallet V.O. Improving anti-hepatitis C virus therapy. Exp Opin Biol Ther 6 (2006) 923-933
14. Alter H. Viral hepatitis. Hepatology 43 (2006) S230-S234
15. Fecht Jr. W.J., and Befeler A.S. Hepatocellular carcinoma: updates in primary prevention. Curr Gastroenterol Rep 6 (2004) 37-43
16. Puoti C., Bellis L., Martellino F., Durola L., Galossi A., Guarisco R., et al. Surveillance of patients with chronic hepatitis C not on antiviral therapy: a practical approach. Rom J Gastroenterol 14 (2005) 141-146
17. Shepard C.W., Finelli L., and Alter M.J. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5 (2005) 558-567
18. Schmunis G.A., and Cruz J.R. Safety of the blood supply in Latin America. Clin Microbiol Rev 18 (2005) 12-29
19. Wong J.B. Hepatitis C: cost of illness and considerations for the economic evaluation of antiviral therapies. Pharmacoeconomics 24 (2006) 661-672
20. Kim W.R., Gross Jr. J.B., Poterucha J.J., Locke III G.R., and Dickson E.R. Outcome of hospital care of liver disease associated with hepatitis C in the United States. Hepatology 33 (2001) 201-206
21. Rockey D.C., and Bissell D.M. Noninvasive measures of liver fibrosis. Hepatology 43 (2006) S113-S120
22. Poynard T., Ratziu V., Benmanov Y., Di Martino V., Bedossa P., and Opolon P. Fibrosis in patients with chronic hepatitis C: detection and significance. Semin Liver Dis 20 (2000) 47-55
23. Ahmed A., and Keeffe E.B. Chronic hepatitis C with normal aminotransferase levels. Gastroenterology 126 (2004) 1409-1415
24. Dillon J.F. Hepatitis C: What is the best treatment?. J Viral Hepat 11 (2004) 23-27
25. Bilodeau M., and Lamarre D. New treatment strategies against hepatitis C viral infection. Can J Gastroenterol 20 (2006) 735-739
26. Manns M.P., Wedemeyer H., and Cornberg M. Treating viral hepatitis C: efficacy, side effects, and complications. Gut 55 (2006) 1350-1359
27. Lok A.S., and McMahon B.J. Chronic hepatitis B: update of recommendations. Hepatology 39 (2004) 857-861
28. Wright T.L., Avunduk C., Dienstag J.L., Freston J.W., Jacobson I.M., Nord H.J., et al. Advancing patient care: integrating new data. Am J Gastroenterol 101 (2006) S32-S39
29. Beasley R.P. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 61 (1988) 1942-1956
30. Lai C.L., Ratziu V., Yuen M.F., and Poynard T. Viral hepatitis B. Lancet 362 (2003) 2089-2094
31. Parana R., and Almeida D. HBV epidemiology in Latin America. J Clin Virol 34 (2005) S130-S133
32. Sociedade, Brasileira, Hepatologia d. Consenso sobre condutas nas Hepatites Virais B e C. GED - Gastroenterologia Endoscopia Digestiva 2005;24:S1-S16.
33. Schalm S.W., Heathcote J., Cianciara J., Farrell G., Sherman M., Willems B., et al. Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial. Gut 46 (2000) 562-568
34. Richman D.D. The impact of drug resistance on the effectiveness of chemotherapy for chronic hepatitis B. Hepatology 32 (2000) 866-867
35. Marcellin P., Lau G.K., Bonino F., Farci P., Hadziyannis S., Jin R., et al. Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B. N Engl J Med 351 (2004) 1206-1217
36. Nery J.R., Weppler D., Rodriguez M., Ruiz P., Schiff E.R., and Tzakis A.G. Efficacy of lamivudine in controlling hepatitis B virus recurrence after liver transplantation. Transplantation 65 (1998) 1615-1621